Chondroitin Sulfate Market Demands, Industry Analysis and Forecast By 2026

Chondroitin Sulfate

A report by ARC estimated that the chondroitin sulfate market will surpass $1.5 billion by 2026, representing an average annual growth rate of 3.3 percent from 2019 to 2026. The report provides analysis of global Chondroitin Sulfate market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

Chondroitin sulfate is also regarded as glycosaminoglycan sulfated glucose (GAG). Chondroitin sulfate comprises a large alternating sugar chain including glucuronic acid and N-acetylgalactosamine. Chondroitin sulfate is a chemical compound discovered in human connective tissues in cartilage and in human joints. Commercial chondroitin sulfate is produced from different animal sources, including pork, bovine, chicken, fish, shark, crocodiles, etc. Chondroitin sulfate is used to stop the growth of osteoarthritis as an alternative medicine. Chondroitin sulphate also helps to decrease pain and inflammation in the articulation. Regular chondroitin sulfate intake contributes to enhanced joint activities. Commercial chondroitin is a glucosamine and chondroitin sulfate combination. Chondroitin sulfate can be used, in addition to enhancing joint function, as an eye fall for waxing teeth, in addition to veterinary use.

Request Free Sample Report Pages for Better Understanding, Download Here

Increased use of joint health supplements as a consequence of increased arthritis among obese and geriatric populations is expected to increase item requirement.

The main variables causing demand for the item are clinical efficiency and the joint health advantages provided. The increasing use of sodium chondroitin pharmaceutical grade sulfate is expected to stimulate development in the sector to heal osteoarthritis. The market is extremely affected by the availability of Chinese dominated products, which are poor and variable in quality, concentration, lacking traceability and deliberate adulteration in the global nutraceutical sector. There are therefore many possibilities for producers and distributors of raw materials to supply quality and standardized products through an auditable supply chain.

Industry challenges include sodium chondroitin sulfate adulteration and the implementation of fresh joint hygiene products. Fluctuating costs of raw materials are expected to adversely affect the item. However, the focus on cost-effective processes will probably boost volumetric manufacturing. The United States, Germany, the United Kingdom, Japan and Brazil are among the main prospective markets for pharmaceutical and nutraceutical sodium chondroitine sulfate.

Key Findings

The US market is expected to achieve around 600 tonnes by 2026 in terms of quantity.

Chondroitin sulfate is controlled and endorsed in Europe as a symptomatic slow-acting osteoarthritis medication (SYSADOA) and its consumption together with glucosamine is preferable.

NutriScience Innovations, LLC, a prominent US sodium chondroitin sulfate company, utilizes European raw materials and generates high-grade 90 percent USP chondroitin sulfate without the use of organic solvents.

Chondroitin sulfate is also regarded as Glycosaminoglycan sulfate (GAG). Chondroitin sulfate is made up of a massive alternating sugar chain including glucuronic acid and N-acetylgalactosamine. Chondroitin sulfate is a chemical compound discovered in human connective tissue discovered in cartilage and body joints. Commercial chondroitin sulfate is produced from a variety of animal sources including pigs, bovine, chicken, fish, shark, crocodiles and other livestock. Chondroitin sulfate is used to stop the development of osteoarthritis as an alternative medicine. Chondroitin sulfate also contributes to a reduction of joint pain and inflammation. Regular chondroitin sulfate intake contributes to better joint activities. Commercial chondroitin sulfate is a glucosamine and chondroitin sulfate combination. Chondroitin sulphate can also serve as an eye drop for sore eyes, in addition to enhancing the joint function, in veterinary applications.

The demand for chondroitin sulfate is anticipated to grow at a greater pace from dietary supplement producers in the near future due to growing healthcare, population aging and a greater emphasis on preventative care and self-care through dietary supplements in order to preserve health and wellbeing. In addition, demand for Chondroitin sulfate increases with rising health-conscious customers and the aging population for joint health supplements.

Key Players & Strategies

Major players included in this report are Bioiberica S.A.U.; Qingdao Wan tulmin Biological Products Co. Ltd.; Sigma-Aldrich, Inc.; HeBei SanXin Industrial Group; Sino Siam Biotechnique Company Limited; Bio-gen Extracts Private Limited; TSI Group Ltd.; ZPD; and SEIKAGAKU CORPORATION.

Key developed economies producers such as the US, France, Germany and the UK. The majority supply to important actors in the nutraceutical and pharmaceutical industries of sodium chondroitin sulfate. The development of osteoarthritis and rising consumption of dietary supplements can be ascribed to this industry.

Due to the existence of a big amount of producers, particularly in China, the industry is extremely divided in nature. Competitive business competition is strong due to increased R&D investments in product development and increased consumer effectiveness. High competition in product final rates and the concentrate on the use of natural ingredients by producers thus denotes elevated market rivalry.

Market Segmentation

Market, by Source

  • Bovine
    • Personal Care & Cosmetics
    • Pharmaceuticals
    • Nutraceuticals
    • Animal Feed
    • Others
  • Swine
    • Personal Care & Cosmetics
    • Pharmaceuticals
    • Nutraceuticals
    • Animal Feed
    • Others
  • Poultry
    • Personal Care & Cosmetics
    • Pharmaceuticals
    • Nutraceuticals
    • Animal Feed
    • Others
  • Shark
    • Personal Care & Cosmetics
    • Pharmaceuticals
    • Nutraceuticals
    • Animal Feed
    • Others
  • Synthetic
    • Personal Care & Cosmetics
    • Pharmaceuticals
    • Nutraceuticals
    • Animal Feed
    • Others

Market, by Application

  • Dietary Supplements
  • Pharmaceutical
  • Cosmetics
  • Veterinary Use

\ Market, by Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Chondroitin Sulfate Market Size, Share & Trends Analysis Report by Source, Application, and Region – Global Industry Size, Share, Trends and Forecast 2019 – 2026” offers detailed insights on global Chondroitin Sulfate market segments with market dynamics and their impact. The report also covers basic technology development policies.

Would like to place an order or any question, please feel free to contact at  sales@acumenresearchandconsulting.com | +1 407 915 4157

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1558

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Leave a Reply

Your email address will not be published. Required fields are marked *

   Contact: +14079154157 | +14089009135 | Email: info@storyoffuture.com

Scroll to Top